Clinical trial

Treating Multiple Sclerosis With Sirolimus, an Immune System Suppressor

NCT00095329

StatusTERMINATED

Study typeINTERVENTIONAL

Start date2003-05-01

PhasePHASE1 / PHASE2

Study timeline

Study start (unknown)2003-05-01Date precision: month

Registry last updated2016-09-22

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Multiple Sclerosis (MS) - Relapsing-remittingunresolved

Interventions

sirolimusBIOLOGICAL

Sponsors & collaborators

National Institute of Allergy and Infectious Diseases (NIAID)lead sponsor

Autoimmunity Centers of Excellencecollaborator

Mapped research locations

BostonMassachusetts, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00095329 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.